Epidemiologic investigation of Burkholderia cepacia acquisition in two pediatric intensive care units

Infection Control and Hospital Epidemiology

Volumn 24, Issue 9, 2003, Pages 707-710

  Loukil, Chawki ^a   Saizou, Carole ^a   Doit, Catherine ^a   Bidet, Philippe ^a   Mariani Kurkdjian, Patricia ^a   Aujard, Yannick ^a   Beaufils, François ^a   Bingen, Edouard ^a  

^a HÔPITAL ROBERT DEBRÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AZTREONAM; CEFEPIME; CEFOPERAZONE; CEFTAZIDIME; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; KANAMYCIN; LATAMOXEF; NEOMYCIN; NETILMICIN; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; TOBRAMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GENETICS; BACTERIAL TRANSMISSION; BACTERIUM ISOLATE; BURKHOLDERIA CEPACIA; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DEVICE; EPIDEMIC; EPIDEMIOLOGICAL DATA; FRANCE; GENOTYPE; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; INSTRUMENT STERILIZATION; INTENSIVE CARE; NEWBORN INTENSIVE CARE; RIBOTYPING; VENTILATOR;

BURKHOLDERIA CEPACIA; BURKHOLDERIA INFECTIONS; CHILD; CHILD, PRESCHOOL; CROSS INFECTION; DISEASE OUTBREAKS; EPIDEMIOLOGIC STUDIES; EQUIPMENT CONTAMINATION; HOSPITAL BED CAPACITY, 500 AND OVER; HOSPITALS, UNIVERSITY; HUMANS; INFANT; INFANT, NEWBORN; INTENSIVE CARE UNITS, NEONATAL; INTENSIVE CARE UNITS, PEDIATRIC; RESPIRATORY THERAPY; RIBOTYPING;

EID: 0141534385     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/502272     Document Type: Article

References (19)

1. Isles A, Maclusky I, Corey M, et al. Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. J Pediatr 1984;104:206-210.
2. Craven DE, Steger KA. Nosocomial pneumonia in the intubated patient: new concepts on pathogenesis and prevention. Infect Dis Clin North Am 1989;3:843-866.
3. Martone WJ, Tablan OC, Jarvis WR. Epidemiology of nosocomial epidemic Pseudomonas cepacia infections. Eur J Epidemiol 1987;3:222-232.
4. Mitchell RG, Hayward AC. Post-operative urinary tract infections caused by contaminated irrigating fluid. Lancet 1966;1:793-795.
5. Pegues CF, Pegues DA, Ford DS, et al. Burkholderia cepacia respiratory tract acquisition: epidemiology and molecular characterization of a large nosocomial outbreak. Epidemiol Infect 1996;116:309-317.
6. Richard JH, Houston ED, Georghiou PR, et al. An outbreak of Burkholderia (formerly Pseudomonas) cepacia respiratory tract colonization and infection associated with nebulized albuterol therapy. Ann Intern Med 1995;122:762-766.
7. Siddiqui AW, Mulligan ME, Mahenthi-Ralingam E, et al. An episodic outbreak of genetically related Burkholderia cepacia among non-cystic fibrosis patients at a university hospital. Infect Control Hosp Epidemiol 2001;22:419-422.
8. Weems JJ Jr. Nosocomial outbreak of Pseudomonas cepacia associated with contamination of reusable electronic ventilator temperature probes. Infect Control Hosp Epidemiol 1990;14:583-583.
9. Centers for Disease Control and Prevention. Nosocomial Burkholderia cepacia infection and colonization associated with intrinsically contaminated mouthwash: Arizona, 1998. MMWR 1998;47:926-928.
10. Van Laer F, Raes D, Vandamme P, et al. An outbreak of Burkholderia cepacia with septicemia on a cardiology ward. Infect Control Hosp Epidemiol 1998;19:112-113.
11. Pittet D. Nosocomial bloodstream infections. In: Wenzel RP, ed. Prevention and Control of Nosocomial Infections, 2nd ed. Baltimore: Williams & Wilkins; 1993:531-552.
12. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Disk Susceptibility Tests, 5th ed. Wayne, PA: National Committee for Clinical Laboratory Standards; 1993. Approved standard M2-A5.
13. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically, 4th ed. Wayne, PA: National Committee for Clinical Laboratory Standards; 1998. Approved standard M7-A4.
14. Bingen E, Denamur E, Lambert-Zechovsky N, et al. DNA restriction fragment length polymorphism differentiates crossed from independent infections in nosocomial Xanthomonas maltophilia bacteremia. J Clin Microbiol 1991;29:1348-1350.
15. Bingen E, Denamur E, Lambert-Zechovsky N, et al. Analysis of DNA restriction fragment length polymorphism extends the evidence for breast milk transmission in Streptococcus agalactiae late-onset neonatal infection. J Infect Dis 1992;165:569-573.
16. Rabkin CS, Jarvis WR, Anderson RL, et al. Pseudomonas cepacia typing systems: collaborative study to assess their potential in epidemiologic investigations. Rev Infect Dis 1989;11:600-607.
17. Holmes A, Nolan R, Taylor R, et al. Epidemic of Burkholderia cepacia transmitted between patients with and without cystic fibrosis. J Infect Dis 1999;179:1197-1205.
18. Ouchi K, Abe M, Karita M, Oguri T, Igari J, Nakazawa T. Analysis of strains of Burkholderia (Pseudomonas) cepacia isolated in a nosocomial outbreak by biochemical and genomic typing. J Clin Microbiol 1995;33:2353-2357.
19. Bingen E, Weber M, Derelle J, et al. Arbitrarily primed polymerase chain reaction as a rapid method to differentiate crossed from independent Pseudomonas cepacia infections in cystic fibrosis patients. J Clin Microbiol 1993;31:2589-2593.